KRKendra Pauline Rumbaugh

Kendra Pauline Rumbaugh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kendra Pauline Rumbaugh has a total of 138 co-authors. Here are the top co-authors by number of shared publications:

  • Derek Fleming

    Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic

    7 shared publications
  • Chase Watters

    Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA

    5 shared publications
  • Jake Everett

    Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, USA

    4 shared publications
  • John A. Griswold

    Deparment of Surgery, Texas Tech University Health Sciences Center, Lubbock, USA

    4 shared publications
  • Abdul N. Hamood

    Departments of Surgery,1 Microbiology and Immunology,2 Pathology,6 Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, 3601 4th St., Lubbock, Texas 79430,7 Life Sciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720,3 Department of Bioengineering, Rice University, 6100 Main, Houston, Texas 77005,4 Department of Biological Sciences, Auburn University, 319 Life Sciences Building, Auburn, Alabama 368495

    3 shared publications
  • Allie Clinton

    Texas Tech University Health Sciences Center, Department of Surgery, MS 8312, 3601 4thStreet, Lubbock Texas 79430 (USA), Tel.: (+1) 806-743-3684, Fax: (+1) 806-743-2113

    3 shared publications

Latest Publications

  • Open Access

    Staphylococcus aureus coagulases increase survival of Pseudomonas aeruginosa during coinfection

    by Bryan Wang, Zoé Horisberger, Trine Zachariasen, Ambrin Farizah Babu, Topi Meuronen, Dennisse Avella, Soile Turunen, Atte Lihtamo, Jonas Stenløkke Madsen, Cody Fell, et al.

  • Open Access

    A murine sinonasal infection model recapitulates key features of clinical chronic rhinosinusitis

    by Emily J. Vanderpool, Kendra P. Rumbaugh

    Introduction. Chronic rhinosinusitis is a difficult-to-treat, recurrent inflammatory condition of the nose and paranasal sinuses with global prevalence. Despite its impact on patient quality of life and its cost to the healthcare system, the pathogenesis of chronic rhinosinusitis (CRS) remains poorly understood. Additionally, while the presence of bacteria in CRS has been confirmed by numerous studies, their influence on disease symptoms is unclear. Disease-relevant models can help resolve these questions. Hypothesis. We hypothesized that bacterial inoculation could drive CRS-associated symptoms in a murine model. Aim. To characterize host–microbe interactions in a murine model of sinonasal bacterial infection. Methodology. Staphylococcus aureus and/or Pseudomonas aeruginosa were inoculated in the nasal cavity of Swiss Webster, C57Bl/6, Balb/c and B6.Cg- Prkdc scid /SzJ severe combined immunodeficient (SCID) mice. Systemic cytokine response was quantified with a multiplexed enzyme-linked immunosorbent assay, and local histological alterations were quantified using haematoxylin and eosin as well as Alcian Blue–Periodic Acid–Schiff-stained sinonasal sections. Results. Intranasal bacterial inoculation induced symptoms of CRS in murine sinonasal cavities. Dual species inoculation generated a unique response compared to single species. Repeated inoculations did not result in bacterial clearance from immunological priming. While Swiss Webster and C57Bl/6 mice demonstrated the greatest magnitude of responses, Balb/c mice demonstrated a protective response, generally downregulating cytokines and attempting to prevent further tissue damage. SCID mice demonstrated effective clearance of P. aeruginosa by innate immunity, but maintenance of S. aureus . Conclusion. Pathogenic bacteria are able to persist and drive the development of symptoms associated with clinical CRS in a murine model. Bacterial interactions and host factors influence CRS-associated inflammation. By investigating host responses from a number of mouse genetic backgrounds, the heterogeneity of disease presentation in CRS can be modelled , and strategies for infection management can be evaluated as potential therapeutic targets.

  • Open Access

    Biofilm Dispersal and Wound Infection Clearance With Preclinical Debridement Agents

    by Rebecca Elizabeth Schneider, Jason Valentino Hamdan, Kendra Pauline Rumbaugh

    Biofilms complicate wound care by causing recurrent infections that are often resistant to debridement and are highly antibiotic‐tolerant. We investigated whether the addition of a biofilm dispersal agent could improve the efficacy of debridement. The previous studies have indicated that a glycoside hydrolase cocktail of alpha‐amylase and cellulase can act as a potent biofilm dispersal agent. With in vitro and ex vivo Pseudomonas aeruginosa biofilm models, we compared glycoside hydrolases against other, clinically relevant, enzymatic debridement agents (papain, bromelain, and collagenase). Glycoside hydrolase biofilm dispersal was dose‐dependent. However, at doses of 1% or above, glycoside hydrolases outperformed, or were comparable, to other enzymatic debridement agents. With our in vivo surgical wound infection model, we evaluated biofilm dispersal using infection dissemination as a proxy. We found that sharp debridement followed by multiple glycoside hydrolase treatments enhanced biofilm dispersal. Furthermore, a single dose of glycoside hydrolase in combination with debridement decreased infection load in acute wounds. Similarly, when we treated established 5‐day‐old infections, we saw a decrease in infection load and no infection dissemination. Overall, our data suggest that debridement enhances the efficacy of a topical antibiotic ointment, allowing for greater infection clearance.


  • Towards improved biofilm models

    by Kendra P. Rumbaugh, Marvin Whiteley

    Biofilms are complex microbial communities that have a critical function in many natural ecosystems, industrial settings as well as in recurrent and chronic infections. Biofilms are highly heterogeneous and dynamic assemblages that display complex responses to varying environmental factors, and those properties present substantial challenges for their study and control. In recent years, there has been a growing interest in developing improved biofilm models to offer more precise and comprehensive representations of these intricate systems. However, an objective assessment for ascertaining the ability of biofilms in model systems to recapitulate those in natural environments has been lacking. In this Perspective, we focus on medical biofilms to delve into the current state-of-the-art in biofilm modelling, emphasizing the advantages and limitations of different approaches and addressing the key challenges and opportunities for future research. We outline a framework for quantitatively assessing model accuracy. Ultimately, this Perspective aims to provide a comprehensive and critical overview of medically focused biofilm models, with the intent of inspiring future research aimed at enhancing the biological relevance of biofilm models.


  • Open Access

    Exploiting cooperative pathogen behaviour for enhanced antibiotic potency: A Trojan horse approach

    by Alper Mutlu, Emily J. Vanderpool, Kendra P. Rumbaugh, Stephen P. Diggle, Ashleigh S. Griffin

    Antimicrobial resistance poses an escalating global threat, rendering traditional drug development approaches increasingly ineffective. Thus, novel alternatives to antibiotic-based therapies are needed. Exploiting pathogen cooperation as a strategy for combating resistant infections has been proposed but lacks experimental validation. Empirical findings demonstrate the successful invasion of cooperating populations by non-cooperating cheats, effectively reducing virulence in vitro and in vivo. The idea of harnessing cooperative behaviours for therapeutic benefit involves exploitation of the invasive capabilities of cheats to drive medically beneficial traits into infecting populations of cells. In this study, we employed Pseudomonas aeruginosa quorum sensing cheats to drive antibiotic sensitivity into both in vitro and in vivo resistant populations. We demonstrated the successful invasion of cheats, followed by increased antibiotic effectiveness against cheat-invaded populations, thereby establishing an experimental proof of principle for the potential application of the Trojan strategy in fighting resistant infections.


  • Open Access

    Microbial Primer: In vivo biofilm

    by Kendra P. Rumbaugh, Thomas Bjarnsholt

    In this primer on biofilms and their role in infections, we trace the historical roots of microbial understanding from Van Leeuwenhoek’s observations to Bill Costerton’s groundbreaking work, which solidified biofilms' significance in infections. In vivo biofilm research, investigating patient samples and utilizing diverse host models, has yielded invaluable insights into these complex microbial communities. However, it comes with several challenges, particularly regarding replicating biofilm infections accurately in the laboratory. In vivo biofilm analyses involve various techniques, revealing biofilm architecture, composition, and behaviour, while gaps in knowledge persist regarding infection initiation and source, diversity, and the Infectious Microenvironment (IME). Ultimately, the study of biofilms in infections remains a dynamic and evolving field poised to transform our approach to combat biofilm-associated diseases.


  • Open Access

    Exploiting Cooperative Pathogen Behavior for Enhanced Antibiotic Potency: A Trojan Horse Approach

    by Alper Mutlu, Emily Vanderpool, Kendra Rumbaugh, Stephen Diggle, Ashleigh Griffin

    Antimicrobial resistance poses an escalating global threat, rendering traditional drug development approaches increasingly ineffective. Thus, novel alternatives to antibiotic-based therapies are needed. Exploiting pathogen cooperation as a strategy for combating resistant infections has been proposed but lacks experimental validation. Empirical findings demonstrate the successful invasion of cooperating populations by non-cooperating cheats, effectively reducing virulence in vitro and in vivo. The idea of harnessing cooperative behaviors for therapeutic benefit involves exploitation of the invasive capabilities of cheats to drive medically beneficial traits into infecting populations of cells. In this study, we employed Pseudomonas aeruginosa quorum sensing cheats to drive antibiotic sensitivity into both in vitro and in vivo resistant populations. We demonstrated the successful invasion of cheats, followed by increased antibiotic effectiveness against cheat-invaded populations, thereby establishing an experimental proof of principle for the potential application of the Trojan strategy in fighting resistant infections.


  • Open Access

    Host-microbe interactions in chronic rhinosinusitis biofilms and models for investigation

    by Emily J. Vanderpool, Kendra P. Rumbaugh


  • Clinical Translation of Biofilm Dispersal Agents

    by Whitni Redman, Derek Fleming, Karin Sauer, Kendra Rumbaugh


  • Dispersing biofilm myths

    by Kendra P. Rumbaugh